Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Endocrinological Investigation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12508908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Prevalence of Various Systemic and Organ-Specific Autoimmune Markers in Addison’s Disease Patients Compared to Healthy Controls

  2025cites this paper
• Bidirectional Mendelian randomization study reveals causal relationships between polymyalgia rheumatica and serum metabolites

  2025cites this paper
• Role of glucocorticoid receptor expression in Chronic Chagas Cardiomyopathy: implications for inflammation and cardiac hypertrophy

  2025cites this paper
• Rheumatic diseases and metabolism: where centre and periphery meet

  2024cites this paper
• Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study

  2024cites this paper
• Concomitant Polymyalgia Rheumatica and Giant Cell Arteritis Associated with Cystic Echinococcosis: A Rare Geriatric Case

  2024cites this paper
• Total network controllability analysis discovers explainable drugs for Covid-19 treatment

  2023cites this paper
• Causal effects of time-varying body size on selected autoimmune disorders: a life course Mendelian randomisation study

  2023cites this paper
• Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review

  2023cites this paper
• Risk of Adrenal Insufficiency in Patients with Polymyalgia Rheumatica Versus Patients with Rheumatoid Arthritis: A Cross-Sectional Study.

  2022cites this paper
• Circadian pain patterns in human pain conditions – A systematic review

  2022cites this paper
• Total Controllability Analysis Discovers Explainable Drugs for Covid-19 Therapy and Prevention

  2022cites this paper
• Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment?

  2021cites this paper
• Activation of Hypothalamic AMP‐Activated Protein Kinase Ameliorates Metabolic Complications of Experimental Arthritis

  2021cites this paper
• Metabolic Profiling of Serum for Osteoarthritis Biomarkers

  2021cites this paper
• Effect of an 8-Week Yoga-Based Lifestyle Intervention on Psycho-Neuro-Immune Axis, Disease Activity, and Perceived Quality of Life in Rheumatoid Arthritis Patients: A Randomized Controlled Trial

  2020cites this paper
• Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease?

  2020cites this paper
• The Selfish Immune System when the Immune System Overrides the ‘Selfish’ Brain

  2020cites this paper
• Rythmes circadiens dans la polyarthrite rhumatoïde

  2020cites this paper
• Circadian rhythms and rheumatoid arthritis.

  2019cites this paper
• The circadian clock at the intercept of sleep and pain.

  2019cites this paper
• Circadian control of pain and neuroinflammation

  2018cites this paper
• Glucocorticoid chronotherapy: a mini-review

  2018cites this paper
• Pathogenesis, Clinical Syndromology and Treatment of Rheumatoid Arthritis

  2017cites this paper
• Psychological and endocrine factors and pain after mastectomy

  2017cites this paper
• Glucocorticoid management in rheumatoid arthritis: morning or night low dose?

  2017cites this paper
• Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

  2016cites this paper
• Glucocorticoids and chronotherapy in rheumatoid arthritis

  2016cites this paper
• Mimicking disruption of brain-immune system-joint communication results in collagen type II-induced arthritis in non-susceptible PVG rats.

  2015cites this paper
• Circadian Use of Glucocorticoids in Rheumatoid Arthritis

  2014cites this paper
• Circadian rhythms in rheumatology - a glucocorticoid perspective

  2014cites this paper
• Morning Glucocorticoids Versus Night Glucocorticoids: The Role of Low-Dose Glucocorticoid Chronotherapy in Rheumatoid Arthritis

  2014cites this paper
• The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis

  2014cites this paper
• Inadequate corticosterone levels relative to arthritic inflammation are accompanied by altered mitochondria/cholesterol breakdown in adrenal cortex: a steroid-inhibiting role of IL-1β in rats

  2014cites this paper
• Do women with premenopausal‐onset rheumatoid arthritis have relative insufficiency or imbalance of adrenocortical steroids?

  2014cites this paper
• Lower Serum Androstenedione Levels in Pre-Rheumatoid Arthritis versus Normal Control Women: Correlations with Lower Serum Cortisol Levels

  2013cites this paper
• Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives

  2013cites this paper
• Sixty years after Hench--corticosteroids and chronic inflammatory disease.

  2012cites this paper
• The resolution of inflammation

  2012cites this paper
• Hypothalamic-pituitary-adrenal axis function in patients with complex regional pain syndrome type 1.

  2012cites this paper
• Association Between Plasma Beta-endorphin and WOMAC Score in Female Patients with Knee Osteoarthritis

  2012cites this paper
• Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering

  2012cites this paper
• Corticotropin Releasing Hormone and Immune Function

  2012cites this paper
• Sixty Years after Hench — Corticosteroids and Chronic Inflammatory Disease

  2012cites this paper
• [Therapy of rheumatic polymyalgia: the pathophysiologic management].

  2011cites this paper
• Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease

  2011cites this paper
• The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype.

  2011cites this paper
• A Case of Transient ACTH Deficiency Associated with Polymyalgia Rheumatica

  2010cites this paper
• A case of apoplectic lymphocytic hypophysitis complicated by polymyalgia rheumatica

  2010cites this paper
• REVIEW

  2010cites this paper
• More Night Than Day — Circadian Rhythms in Polymyalgia Rheumatica and Ankylosing Spondylitis

  2010cites this paper
• Arthritis Treated with Nighttime-Release Prednisone Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid

  2010cites this paper
• Adrenal cortisol secretion capacity in children and adolescents with new-onset, mild Crohn's disease.

  2010cites this paper
• Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Nighttime-Release Prednisone

  2010cites this paper
• The Hypothalamic–Pituitary–Adrenal Axis in Women with Differentiated Thyroid Cancer

  2010cites this paper
• Willtreatmentofrheumatoid arthritiswithanIL-6Rinhibitor helpfacilitatethe'ageof remission'?

  2009cites this paper
• ARTICULAR AND SYSTEMIC THERAPY FOR RHEUMATOID DISEASE

  2009cites this paper
• Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the ‘age of remission’?

  2009cites this paper
• Hypothalamic-pituitary-adrenal axis in patients with ankylosing spondylitis

  2008cites this paper
• Chapter 9 Adrenal Involvement in Systemic Autoimmune Diseases

  2008cites this paper
• Polymyalgia rheumatica vs late-onset rheumatoid arthritis.

  2008cites this paper
• Trattamento della polimialgia reumatica: l'approccio fisiopatologico Therapy of rheumatic polymyalgia: the pathophysiologic management

  2007cites this paper
• Cytokines and the immune-neuroendocrine network: What did we learn from infection and autoimmunity?

  2007cites this paper
• Treatment of polymyalgia rheumatica: a physiopathologic approach

  2007cites this paper
• Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis

  2006cites this paper
• Glucocorticoid Effects on Adrenal Steroids and Cytokine Responsiveness in Polymyalgia Rheumatica and Elderly Onset Rheumatoid Arthritis

  2006cites this paper
• Immune-Neuroendocrine Interactions and Autoimmune Diseases

  2006cites this paper
• Circadian Rhythms

  2006cites this paper
• Evaluation of the hypothalamic–pituitary–adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls

  2006influential citation
• Polimialgia reumtica y artritis reumatoide

  2005cites this paper
• The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis

  2005cites this paper
• Circadian rhythms and arthritis.

  2005cites this paper
• Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells.

  2004cites this paper
• Involvement and Role of the Hypothalamo-pituitary-adrenal (HPA) Stress Axis in Animal Models of Chronic Pain and Inflammation

  2004cites this paper
• Review Neural immune pathways and their connection to inflammatory

  2003cites this paper
• Neural immune pathways and their connection to inflammatory diseases

  2003cites this paper
• Garlic extract and two diallyl sulphides inhibit methicillin-resistant Staphylococcus aureus infection in BALB/cA mice.

  2003cites this paper
• Polymyalgia Rheumatica Vs Late-onset Rheumatoid Arthritis Polymyalgia Rheumatica Differs from Ra Genetic and Clinical Differences Different Markers of Inflammation Hormonal Differences

  year unknowncites this paper